Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coley Pharmaceutical Group Inc.

Division of Pfizer Inc.
www.coleypharma.com

Latest From Coley Pharmaceutical Group Inc.

Appointments: Gilead, Biogen, Nordic Nanovector, Neon Therapeutics, Achaogen and vasopharm

This week's roundup includes executive appointments by Gilead Sciences, Nordic Nanovector, Mereo BioPharma, vasopharm and Rigontec. Biogen has also appointed two executives to its planned spin-off company, Bioverativ.

Appointments

Pfizer Oncology: Big Strides But Not Blockbuster Size

Pfizer’s emphasis on oncology has yielded three new drug approvals in the last 20 months and another two promising drugs on the horizon. It is a notable achievement, but investors may be wondering when the results are going to be felt on the top line.

BioPharmaceutical Clinical Trials

Verastem Joins The Public Markets With A Strong IPO

Verastem IPO’d at $10 per share on Jan. 26, despite having only preclinical assets in its pipeline. Strong interest from large companies for cancer stem cell therapies helped contribute to the price.

BioPharmaceutical Business Strategies

Financings Of The Fortnight Applies Its Own Lens To Early-Stage Investments

Plus news on recent financings by Neurocrine Biosciences, Prosensa, RaNA Therapeutics and Trius Therapeutics.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • CpG ImmunoPharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Robert L Bratzler, PhD, Pres. & CEO
    Ted Hibben, VP, Bus. Dev.
    Arthur M Krieg, MD, EVP, R&D & CSO
  • Contact Info
  • Coley Pharmaceutical Group Inc.
    Phone: (781) 431-9000
    93 Worcester St., Ste. 101
    Wellesley, MA 02481
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register